Trials / Recruiting
RecruitingNCT06417177
Impact of Early Aging and Menopause on the Vascular Responses to Hypoxia
- Status
- Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 75 (estimated)
- Sponsor
- University of Missouri-Columbia · Academic / Other
- Sex
- Female
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to examine hypoxic vasodilation and the role of beta-adrenergic receptors in younger premenopausal, perimenopausal, and older postmenopausal women.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | Participants will receive a placebo in pill form. |
| DRUG | Propranolol | Participants will receive oral propranolol (1 mg/kg). |
| DRUG | Gemtesa | Participants will receive oral gemtesa (75 mg). |
Timeline
- Start date
- 2024-06-03
- Primary completion
- 2026-07-01
- Completion
- 2026-07-01
- First posted
- 2024-05-16
- Last updated
- 2025-09-09
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06417177. Inclusion in this directory is not an endorsement.